• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 3. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473

Professional Introduction to 3-4-(Bromomethyl)phenyl-5-methyl-1,2,4-oxadiazole (CAS No. 256956-42-0)

3-4-(Bromomethyl)phenyl-5-methyl-1,2,4-oxadiazole (CAS No. 256956-42-0) is a highly versatile heterocyclic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the oxadiazole family, which is well-known for its broad spectrum of biological activities and potential applications in drug development. The presence of both bromomethyl and methyl substituents on the phenyl ring enhances its reactivity, making it a valuable intermediate in synthetic chemistry.

The structure of 3-4-(Bromomethyl)phenyl-5-methyl-1,2,4-oxadiazole consists of a benzene ring substituted with a bromomethyl group at the 3 and 4 positions and a methyl group at the 5 position, linked to a central 1,2,4-oxadiazole ring. This unique arrangement imparts distinct chemical properties that make it particularly useful in organic synthesis and medicinal chemistry. The oxadiazole core is known for its stability and ability to engage in various chemical reactions, including nucleophilic substitution, cycloaddition, and coupling reactions.

In recent years, there has been a surge in research focused on developing novel therapeutic agents derived from oxadiazole derivatives. The compound 3-4-(Bromomethyl)phenyl-5-methyl-1,2,4-oxadiazole has been extensively studied for its potential applications in the treatment of various diseases. Its structural features allow for modifications that can enhance its pharmacological properties, making it a promising candidate for drug discovery.

One of the most compelling aspects of this compound is its utility as a building block in the synthesis of more complex molecules. The bromomethyl group provides a reactive site for further functionalization, enabling chemists to introduce additional substituents or link the compound to other pharmacophores. This flexibility has led to its use in the development of novel inhibitors targeting enzymes involved in cancer metabolism. For instance, studies have shown that derivatives of this compound can inhibit key enzymes such as lactate dehydrogenase (LDH) and pyruvate kinase (PK), which are overexpressed in many cancer cells.

The pharmaceutical industry has been particularly interested in oxadiazole derivatives due to their ability to modulate biological pathways associated with inflammation and oxidative stress. Research indicates that compounds like 3-4-(Bromomethyl)phenyl-5-methyl-1,2,4-oxadiazole can exhibit anti-inflammatory properties by inhibiting the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). Additionally, their antioxidant effects have been explored as potential treatments for neurodegenerative diseases where oxidative damage plays a significant role.

In terms of synthetic methodologies, 3-4-(Bromomethyl)phenyl-5-methyl-1,2,4-oxadiazole serves as an excellent precursor for constructing more intricate molecular architectures. The bromomethyl functionality allows for palladium-catalyzed cross-coupling reactions such as Suzuki-Miyaura and Heck couplings, which are widely used in pharmaceutical synthesis to create carbon-carbon bonds between aryl or vinyl groups. These reactions are particularly valuable for introducing aromatic or alkenyl moieties into the molecule without disrupting the oxadiazole core.

The methyl group at the 5 position also contributes to the compound's reactivity by influencing electronic distribution around the oxadiazole ring. This feature can be exploited to fine-tune the pharmacokinetic properties of derivatives by altering solubility and metabolic stability. For example, modifications at this position have been shown to enhance oral bioavailability and prolong half-life in vivo.

The growing body of research on oxadiazole derivatives underscores their significance in modern drug discovery. Innovations in synthetic chemistry have enabled access to increasingly complex derivatives with tailored biological activities. As a result, compounds like 3-4-(< strong>Bromomethyl strong>)< strong>phenyl strong>-5-methyl -1 ,2 ,4 -< strong>Oxadiazole strong>(CAS No. 256956 -42 -0) continue to be explored for their potential therapeutic applications across multiple disease areas.

In conclusion, 3-4-(< strong>Bromomethyl strong>)< strong>phenyl strong>-5-methyl -1 ,2 ,4 -< strong>Oxadiazole strong>(CAS No. 256956 -42 -0) is a multifaceted compound with significant implications in pharmaceutical research and development. Its unique structural features make it an invaluable intermediate for synthesizing novel therapeutic agents targeting various diseases. As research progresses, further exploration of its potential will undoubtedly lead to innovative treatments that improve human health outcomes.

• 1198-98-7(5-Methyl-3-phenyl-1,2,4-oxadiazole)
• 87944-75-0(1,2,4-Oxadiazole, 5-methyl-3-(3-methylphenyl)-)
• 852180-61-1(4-(5-Methyl-1,2,4-oxadiazol-3-yl)phenylmethanol)
• 87944-74-9(1,2,4-Oxadiazole, 5-methyl-3-(2-methylphenyl)-)
• 253273-90-4(3-3-(Bromomethyl)Phenyl-5-Methyl-1,2,4-Oxadiazole)
• 118183-92-9(3-(4-Bromophenyl)-5-methyl-1,2,4-oxadiazole)
• 160377-57-1(3-(3-Bromophenyl)-5-methyl-1,2,4-oxadiazole)
• 852180-60-0(4-(5-Methyl-1,2,4-oxadiazol-3-yl)benzaldehyde)
• 362529-03-1(5-4-(Bromomethyl)Phenyl-3-Methyl-1,2,4-Oxadiazole)
• 89612-19-1(1,2,4-Oxadiazole, 3-(2,6-dimethylphenyl)-5-methyl-)